Chapkin Lab is pleased to announce the funding of a new grant! Attempts to target aberrant Wnt signaling using drugs still face multiple hurdles due to poor tumor cell targeting, negative side effects associated with required long-term treatments and a poor understanding of the mechanisms of action. Consequently, there is an urgent need to further […]
Research in the Chapkin lab focuses on dietary/microbial modulators related to the prevention of cancer and chronic inflammatory diseases. The lab has been continuously funded by the National Institutes of Health (NIH) for the past 32 years.
We are pleased to announce that our paper on, “Loss of aryl hydrocarbon receptor potentiates FoxM1 signaling to enhance self‐renewal of colonic stem and progenitor cells” has been published in the EMBO Journal and can now be accessed online. Authors include: Huajun Han, Laurie A Davidson, Yang‐Yi Fan, Jennifer S Goldsby, Grace Yoon, Un‐Ho Jin, […]
Chapkin Lab is pleased to announce that Dr. Robert Chapkin was awarded a $250,000 grant from The Cancer Prevention and Research Institute of Texas (CPRIT). These funds will support the “Targeting Plasma Membrane Spatial Dynamics to Suppress Obesity-Induced Colon Cancer” project. Research in the Chapkin lab focuses on dietary/microbial modulators related to the prevention of cancer and chronic inflammatory diseases. […]
The Chapkin Lab is pleased to announce the promotion of Dr . Alfredo Erazo-Oliveras and Dr. Xiaoli Wang from Post-Doctoral Researchers to Assistant Research Scientists. Alfredo has been with the Chapkin Lab for 4 years and has frequently been recognized for outstanding achievement. Alfredo’s main research focus is to establish the role of oncogenic APC on […]